CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Scope & Guideline

Navigating Trends in Eukaryotic Gene Research

Introduction

Welcome to your portal for understanding CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1045-4403
PublisherBEGELL HOUSE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationCRIT REV EUKAR GENE / Crit. Rev. Eukaryot. Gene Expr.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address50 NORTH ST, DANBURY, CT 06810

Aims and Scopes

The journal 'Critical Reviews in Eukaryotic Gene Expression' is dedicated to advancing the understanding of gene expression mechanisms and their implications in various biological processes and diseases, particularly cancer. It emphasizes the integration of molecular biology, genetics, and bioinformatics to elucidate the complexities of gene regulation and expression.
  1. Gene Regulation Mechanisms:
    The journal focuses on the diverse mechanisms that regulate gene expression, including epigenetic modifications, transcriptional control, and post-transcriptional modifications like RNA splicing and degradation.
  2. Cancer Biology and Therapeutics:
    A significant portion of the published research addresses the role of gene expression in cancer biology, exploring how alterations in gene regulation contribute to tumorigenesis, metastasis, and therapeutic resistance.
  3. Molecular Pathways and Signaling:
    Research articles frequently investigate specific signaling pathways and their role in modulating gene expression, particularly in the context of various diseases, including cancer and neurodegenerative disorders.
  4. Comparative Genomics and Transcriptomics:
    The journal also highlights studies that employ comparative genomics and transcriptomic analyses to understand gene expression patterns across different species or cancer types, providing insights into evolutionary biology and disease mechanisms.
  5. Stem Cells and Regenerative Medicine:
    Another area of focus is the role of gene expression in stem cell biology and regenerative medicine, exploring how gene regulation affects stem cell differentiation and therapeutic applications.
The journal has evolved over time, with certain themes gaining traction in recent publications. This section highlights the emerging trends that reflect the current research landscape in gene expression and its applications.
  1. Cancer Immunotherapy and Gene Expression:
    Recent publications show a growing interest in the relationship between gene expression profiles and cancer immunotherapy outcomes, highlighting the importance of understanding immune evasion mechanisms and potential biomarkers for therapy response.
  2. Single-Cell Transcriptomics:
    There is an increasing emphasis on single-cell transcriptomic studies, which allow for a more nuanced understanding of gene expression heterogeneity within tumors and other tissues, providing insights into cellular dynamics and disease progression.
  3. Multi-Omics Approaches:
    The integration of various omics data (genomics, transcriptomics, proteomics) is becoming a prominent theme, reflecting a trend towards comprehensive analyses that provide a holistic view of gene regulation and its impact on health and disease.
  4. Role of Epigenetics in Disease:
    The exploration of epigenetic modifications and their influence on gene expression is gaining more attention, particularly in the context of cancer and chronic diseases, indicating a shift towards understanding the complex regulatory networks governing gene activity.
  5. Therapeutic Applications of Gene Editing:
    Emerging research is increasingly focusing on gene editing technologies, such as CRISPR, and their potential therapeutic applications in treating genetic disorders and cancers, reflecting a significant trend towards translational research.

Declining or Waning

While the journal has consistently focused on gene expression and its biological implications, certain topics have shown signs of declining emphasis in recent publications. This section outlines the themes that appear to be waning in prominence.
  1. Non-Coding RNA Studies:
    Although non-coding RNAs, including microRNAs and long non-coding RNAs, were once a major focus, the frequency of papers specifically examining their roles in gene regulation has decreased, suggesting a shift towards more mechanistic and pathway-oriented studies.
  2. Basic Research on Gene Expression Techniques:
    There appears to be a declining interest in publishing foundational research on traditional gene expression techniques and methodologies, as the field moves towards more integrative and systems biology approaches.
  3. Environmental Influences on Gene Expression:
    Research exploring the impact of environmental factors on gene expression, while still relevant, has seen fewer dedicated studies, indicating a possible shift towards more direct investigations of genetic and epigenetic mechanisms.

Similar Journals

FEBS LETTERS

Advancing the Frontiers of Biological Science
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

GENOME

Elevating the Standards of Genetic Scholarship
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0831-2796Frequency: 12 issues/year

GENOME is a leading peer-reviewed journal published by Canadian Science Publishing, dedicated to advancing the field of genetics, biotechnology, and molecular biology. With a strong commitment to disseminating high-quality research, GENOME has earned a reputable spot in the academic community, boasting a Q2 classification in Biotechnology and Medicine (miscellaneous), and a Q3 rank in Genetics and Molecular Biology for 2023. The journal, identified by its ISSN 0831-2796 and E-ISSN 1480-3321, publishes innovative studies that span from 1987 to 2024, ensuring a rich historical context while addressing contemporary challenges in the field. Researchers and professionals are encouraged to contribute and engage with content that shapes the landscape of genetic research. Although the journal does not currently provide open access, it remains a vital resource for those committed to the exploration of genomic sciences, making it an essential read for both seasoned researchers and students alike.

NATURE REVIEWS GENETICS

Exploring the Depths of Genetic Innovation.
Publisher: NATURE PORTFOLIOISSN: 1471-0056Frequency: 12 issues/year

NATURE REVIEWS GENETICS, published by NATURE PORTFOLIO, stands as a leading journal in the field of genetics, boasting a remarkable reputation reflected in its Q1 ranking across multiple categories including Genetics, Clinical Genetics, and Molecular Biology. With an impressive percentile of 99th in both Genetics and Clinical Genetics, as well as a solid rank in Molecular Biology, this journal is pivotal for researchers, professionals, and students alike who seek to stay informed on the latest advancements and comprehensive reviews in genetic research. The journal's scope encompasses a wide array of topics, providing in-depth insights from fundamental genetic principles to clinical applications, underscoring its importance in bridging basic science and medical practice. Though not an open-access publication, it remains accessible through various academic institutions, enhancing its reach and influence within the scientific community. With publication years spanning from 2000 to 2024, NATURE REVIEWS GENETICS continues to shape the future of genetics research and education.

Cell Discovery

Advancing the Frontiers of Cellular Science
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

MOLECULAR AND CELLULAR BIOLOGY

Pioneering Research in Cell Biology Excellence
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.

CURRENT OPINION IN GENETICS & DEVELOPMENT

Uncovering the latest trends in genetics.
Publisher: CURRENT BIOLOGY LTDISSN: 0959-437XFrequency: 6 issues/year

CURRENT OPINION IN GENETICS & DEVELOPMENT is a prestigious journal published by CURRENT BIOLOGY LTD that offers an insightful platform for the latest developments and emerging trends in the fields of genetics and developmental biology. Established in 1991 and set to continue until at least 2024, this journal achieves notable recognition in the academic community with a Q1 classification in both its major categories as of 2023. With a Scopus rank placing it within the top quartile for both genetics and developmental biology, it serves as an essential resource for researchers, professionals, and students seeking to enhance their understanding of genetic mechanisms and developmental processes. While currently not an open-access journal, readers can explore the collection of high-quality articles that contribute to shaping contemporary scientific discourse and fostering innovation within these dynamic fields. For those dedicated to advancing their research and knowledge, CURRENT OPINION IN GENETICS & DEVELOPMENT stands as a vital and influential academic publication.

Molecular Cell

Advancing the Frontiers of Cell and Molecular Science.
Publisher: CELL PRESSISSN: 1097-2765Frequency: 24 issues/year

Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.

Transcription-Austin

Connecting Scholars through High-Impact Research
Publisher: TAYLOR & FRANCIS INCISSN: 2154-1264Frequency: 5 issues/year

Transcription-Austin is a leading academic journal published by Taylor & Francis Inc., dedicated to the rapidly evolving fields of biochemistry, biotechnology, and genetics. As a testament to its significance in the academic community, it has been ranked in the Q1 category across all three fields, establishing itself as a premier platform for high-quality research and innovative findings since its inception in 2010. With an H-index reflecting robust academic influence, Transcription-Austin invites contributions that enhance our understanding of transcriptional processes and their implications in various biological contexts. Researchers and professionals alike will find value in its rigorous peer-reviewed articles, which set the stage for future advancements in molecular biology. The journal is based in the United Kingdom and provides a critical resource for scholars aiming to disseminate cutting-edge research to a global audience.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Advancing the Frontier of Biochemical Knowledge
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

MOLECULAR GENETICS AND GENOMICS

Pioneering the Future of Genetic Understanding
Publisher: SPRINGER HEIDELBERGISSN: 1617-4615Frequency: 6 issues/year

MOLECULAR GENETICS AND GENOMICS is a distinguished journal published by SPRINGER HEIDELBERG that serves as a pivotal platform for the communication of cutting-edge research and developments in the fields of genetics, molecular biology, and medicine. With an ISSN of 1617-4615 and an E-ISSN of 1617-4623, this journal has established itself since its inception in 1994 as a significant resource for researchers aiming to explore the complexities of genetic interactions and their implications in various biological systems. The journal is indexed in Scopus, with respectable rankings in the Genetics, Molecular Biology, and Biochemistry categories, showcasing its position within the academic community. It is categorized in the 2023 rankings as Q3 in Genetics, Q2 in Medicine (miscellaneous), and Q3 in Molecular Biology, indicating its relevance and quality in the scientific discourse. The journal also promotes open access, ensuring that researchers and professionals can easily share and advance knowledge in the rapidly evolving disciplines of molecular genetics and genomics. As the journal continues to bridge the gap between experimental and theoretical research, it presents a vital space for innovation, fostering collaborations and scholarly exchange among its readership.